Jeffrey Leppert
Adult Health · Medford, ORNPI 1811027055
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 55 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Collegium Pharmaceutical, Inc. at 58.6% of the total. Reporting peaked in 2022 at $289 and has fallen 91.5% since, to $25 in 2025.
Across 55 payments — averaging $16.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Collegium Pharmaceutical, Inc.$525
- Boston Scientific$100
- Abbott$62
- GRT US Holding, Inc.$48
- Amgen$40
- Saluda Medical Americas, Inc.$39
- plus $82 from 4 others
What the payments were for
- Food & beverage$896100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 40 | $525 |
| Boston Scientific | 1 | $100 |
| Abbott | 3 | $62 |
| GRT US Holding, Inc. | 3 | $48 |
| Amgen | 2 | $40 |
| Saluda Medical Americas, Inc. | 2 | $39 |
| Nalu Medical, Inc. | 1 | $31 |
| AbbVie | 1 | $22 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| Avanos Medical | 1 | $13 |
How this compares
$896 in reported general payments places this provider in the 75th percentile of 96 adult health providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 31 | $28,463 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,001 | $27,517 |
| OxycontinOxycodone Hcl | 28 | $17,185 |
| Buprenorphine | 39 | $16,044 |
| Buprenorphine Hcl | 240 | $12,523 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 383 | $10,644 |
| ButransBuprenorphine | 20 | $10,529 |
| Oxycodone Hcl | 547 | $10,169 |
| Gabapentin | 268 | $6,397 |
| Morphine Sulfate ErMorphine Sulfate | 219 | $4,495 |
| Tizanidine Hcl | 140 | $4,417 |
| Fentanyl | 44 | $3,078 |
| Pregabalin | 83 | $2,784 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 35 | $1,830 |
| Morphine Sulfate | 72 | $1,369 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca | $525 | $28,46331 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 96 adult health providers in Oregon.
Other adult health in Medford
- Adria ThomasMedford$3K
- Christine StanekMedford$597
- William CastleberryMedford$563
- Lakshi AldredgePortland$393K
- Deborah JonesLake Oswego$44K
- Erin MyklebustPortland$14K
- Yasmine LeePortland$11K
- Terri WarrenPortland$10K
- Brenda BrewerTualatin$7K
- Rachael GreerSeaside$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.